Labeler
BluePoint Laboratories NDC Codes
BluePoint Laboratories lists 349 finished drug products in the FDA NDC Directory under NDC labeler code 68001.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Enoxaparin Sodium, Nadolol, Dasatinib, doxorubicin hydrochloride, Metoprolol Succinate, Aprepitant, Zenatane, Decitabine, Labetalol Hydrochloride, Cyclophosphamide, Fluoxetine, Etoposide, Haloperidol decanoate, leucovorin calcium, Mitomycin
- Active ingredients
- Enoxaparin sodium, Nicotine, Nadolol, Dasatinib, Doxorubicin hydrochloride, Metoprolol succinate, Isotretinoin, Decitabine, Labetalol hydrochloride, Cyclophosphamide, Aprepitant, Fluoxetine hydrochloride
- NDC labeler codes
- 68001
- Strengths (from the 100 most recently listed products)
- Doxorubicin hydrochloride 2 mg/mL; Enoxaparin sodium 100 mg/mL; Etoposide 20 mg/mL; Decitabine 50 mg/10mL; Nicotine 7 mg/24h; Nicotine 14 mg/24h; Nicotine 21 mg/24h; Nadolol 20 mg/1; Nadolol 40 mg/1; Nadolol 80 mg/1; Enoxaparin sodium 150 mg/mL; Fluorouracil 50 mg/mL; Cisplatin 1 mg/mL; Palonosetron hydrochloride .25 mg/5mL; Labetalol hydrochloride 300 mg/1; Paclitaxel 6 mg/mL; Teriparatide 250 ug/mL; Cyclophosphamide 500 mg/25mL; Cyclophosphamide 1 g/50mL; Cyclophosphamide 2 g/100mL
- Dosage forms
- Injection, Tablet, Tablet, Film coated, Injection, Powder, Lyophilized, For solution, Patch, Extended release, Capsule, Injection, Solution, Tablet, Extended release, Capsule, Gelatin coated, Injection, Solution, Concentrate, Injection, Suspension, Liposomal, Injection, Powder, For solution, Injectable, Liposomal, Solution, Tablet, Film coated, Extended release, Kit, Patch, Injection, Powder, Lyophilized, For suspension, Gel, Spray, Capsule, Extended release
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Transdermal, Topical, Ophthalmic, Nasal
- Drug classes (FDA established)
- beta-Adrenergic Blocker, Nucleoside Metabolic Inhibitor, Kinase Inhibitor, Low Molecular Weight Heparin, Cholinergic Nicotinic Agonist, Anthracycline Topoisomerase Inhibitor, Serotonin Reuptake Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Retinoid, Microtubule Inhibitor, Topoisomerase Inhibitor, Typical Antipsychotic, Folate Analog, Alkylating Drug, Anti-epileptic Agent, Mood Stabilizer, Nonsteroidal Anti-inflammatory Drug, Aminoketone, Bisphosphonate, Platinum-based Drug, Serotonin-3 Receptor Antagonist, Parathyroid Hormone Analog, Histamine-1 Receptor Antagonist, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Cytochrome P450 17A1 Inhibitor, Amide Local Anesthetic, Antiarrhythmic, Corticosteroid, Opioid Antagonist, Vitamin B12, Estrogen Receptor Antagonist, Osmotic Laxative, Potassium Salt
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 131 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Haloperidol decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | 68001-657 | 68001-0657-51 | — |
| Haloperidol decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | 68001-658 | 68001-0658-4168001-0658-52 | — |
| Haloperidol decanoate | Haloperidol decanoate 500 mg/5mL | InjectionIntramuscular | 68001-659 | 68001-0659-41 | — |
| divalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Film coated, Extended releaseOral | 68001-646 | 68001-0646-0068001-0646-03 | — |
| divalproex sodium | Divalproex sodium 500 mg/1 | Tablet, Film coated, Extended releaseOral | 68001-647 | 68001-0647-0068001-0647-03 | — |
| Diclofenac Sodiumdiclofenac sodium topical gel, 1% | Diclofenac sodium 10 mg/g | GelTopical | 68001-621 | 68001-0621-45 | — |
| leucovorin calcium | Leucovorin calcium 100 mg/10mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 68001-648 | 68001-0648-36 | — |
| leucovorin calcium | Leucovorin calcium 200 mg/20mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 68001-649 | 68001-0649-37 | — |
| leucovorin calcium | Leucovorin calcium 350 mg/17.5mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 68001-650 | 68001-0650-38 | — |
| methylprednisolone | Methylprednisolone 4 mg/1 | TabletOral | 68001-624 | 68001-0624-01 | — |
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | 68001-641 | 68001-0641-41 | — |
| Decitabine | Decitabine 50 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-642 | 68001-0642-41 | — |
| Naloxone Hydrochloride | Naloxone hydrochloride 4 mg/.1mL | SprayNasal | 68001-645 | 68001-0645-45 | — |
| Capecitabine | Capecitabine 500 mg/1 | Tablet, Film coatedOral | 68001-644 | 68001-0644-07 | — |
| Capecitabine | Capecitabine 150 mg/1 | Tablet, Film coatedOral | 68001-643 | 68001-0643-06 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-633 | 68001-0633-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-635 | 68001-0635-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | 68001-638 | 68001-0638-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | 68001-639 | 68001-0639-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-637 | 68001-0637-42 | — |
| Cyanocobalamin | Cyanocobalamin 1000 ug/mL | Injection, SolutionIntramuscular, Subcutaneous | 68001-640 | 68001-0640-60 | — |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | 68001-628 | 68001-0628-32 | — |
| Fluorouracil | Fluorouracil 50 mg/mL | Injection, SolutionIntravenous | 68001-627 | 68001-0627-27 | — |
| Fulvestrant | Fulvestrant 50 mg/mL | InjectionIntramuscular | 68001-626 | 68001-0626-85 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-634 | 68001-0634-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-636 | 68001-0636-42 | — |
| Azacitidine | Azacitidine 100 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 68001-620 | 68001-0620-54 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Suspension, LiposomalIntravenous | 68001-629 | 68001-0629-2668001-0629-36 | — |
| Nadolol | Nadolol 20 mg/1 | TabletOral | 68001-630 | 68001-0630-00 | — |
| Nadolol | Nadolol 40 mg/1 | TabletOral | 68001-631 | 68001-0631-00 | — |
| Nadolol | Nadolol 80 mg/1 | TabletOral | 68001-632 | 68001-0632-00 | — |
| Imatinib Mesylate | Imatinib mesylate 100 mg/1 | Tablet, Film coatedOral | 68001-622 | 68001-0622-05 | — |
| Imatinib Mesylate | Imatinib mesylate 400 mg/1 | Tablet, Film coatedOral | 68001-623 | 68001-0623-04 | — |
| Mitomycin | Mitomycin 40 mg/80mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-617 | 68001-0617-79 | — |
| Potassium Chloride | Potassium chloride 750 mg/1 | Capsule, Extended releaseOral | 68001-619 | 68001-0619-0068001-0619-03 | — |
| Mitomycin | Mitomycin 5 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-615 | 68001-0615-36 | — |
| Nicotine Transdermal System | Nicotine 7 mg/24h | Patch, Extended releaseTransdermal | 68001-432 | 68001-0432-8868001-0432-90 | — |
| Nicotine Transdermal System | Nicotine 14 mg/24h | Patch, Extended releaseTransdermal | 68001-433 | 68001-0433-8868001-0433-90 | — |
| Nicotine Transdermal System | Nicotine 21 mg/24h | Patch, Extended releaseTransdermal | 68001-434 | 68001-0434-8868001-0434-9068001-0434-91 | — |
| Mitomycin | Mitomycin 20 mg/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-616 | 68001-0616-77 | — |
| Decitabine | Decitabine 50 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-618 | 68001-0618-37 | — |
| Bupropion hydrochloride | Bupropion hydrochloride 300 mg/1 | TabletOral | 68001-614 | 68001-0614-0368001-0614-0468001-0614-05 | — |
| Bupropion hydrochloride | Bupropion hydrochloride 150 mg/1 | TabletOral | 68001-613 | 68001-0613-0368001-0613-0468001-0613-05 | — |
| Zoledronic acid | Zoledronic acid 5 mg/100mL | InjectionIntravenous | 68001-611 | 68001-0611-33 | — |
| Zoledronic acid | Zoledronic acid 4 mg/5mL | Injection, Solution, ConcentrateIntravenous | 68001-610 | 68001-0610-25 | — |
| Diclofenac sodium | Diclofenac sodium 100 mg/1 | Tablet, Film coatedOral | 68001-612 | 68001-0612-00 | — |
| Cisplatin | Cisplatin 1 mg/mL | Injection, SolutionIntravenous | 68001-608 | 68001-0608-24 | — |
| Cisplatin | Cisplatin 1 mg/mL | Injection, SolutionIntravenous | 68001-609 | 68001-0609-33 | — |
| Escitalopram | Escitalopram oxalate 5 mg/1 | Tablet, Film coatedOral | 68001-591 | 68001-0591-00 | — |
| Escitalopram | Escitalopram oxalate 10 mg/1 | Tablet, Film coatedOral | 68001-592 | 68001-0592-0068001-0592-08 | — |
BluePoint Laboratories: common questions
- What is BluePoint Laboratories's NDC labeler code?
- 68001. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for BluePoint Laboratories?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.